Literature DB >> 23224237

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.

Christopher I Li1, Elisabeth F Beaber, Mei-Tzu Chen Tang, Peggy L Porter, Janet R Daling, Kathleen E Malone.   

Abstract

Aspects of reproductive history are among the most well-established breast cancer risk factors. However, relatively little is known about how they influence risk of different molecular subtypes of breast cancer, particularly among younger women. Using data from a population-based case-control study of women 20-44 years of age, we assessed the relationships between various reproductive factors and risk of estrogen receptor positive (ER+), triple-negative, and HER2-overexpressing breast cancers. Detailed reproductive histories were obtained through structured interviewer administered in-person questionnaires. Reproductive histories among control women (n = 941) were compared to those of ER+ cases (n = 781), triple-negative cases (n = 180), and HER2-overexpressing cases (n = 60) using polytomous logistic regression. Age at menarche, parity, and number of full-term pregnancies were similarly associated with risk of all three breast cancer subtypes. In contrast, age at first live birth, the interval between age at menarche and age at first birth, and breastfeeding were inversely associated with risk of triple-negative breast cancer (P values for trend 0.002, 0.006 and 0.018, respectively), but were not associated with risk of ER+ or HER2-overexpressing cancers. A strong inverse association between breastfeeding and risk of triple-negative breast cancer has now been consistently observed across numerous studies, and at present it is the most well-established protective factor for this aggressive and lethal form of breast cancer. Further studies clarifying the biological mechanisms underlying this relationship and confirming our results with respect to age at first birth and the interval between age at menarche and age at first birth are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224237      PMCID: PMC3547981          DOI: 10.1007/s10549-012-2365-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  30 in total

1.  Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality.

Authors:  N Andrieu; T Prevost; T E Rohan; E Luporsi; M G Lê; M Gerber; D G Zaridze; Y Lifanova; R Renaud; H P Lee; S W Duffy
Journal:  Int J Epidemiol       Date:  2000-04       Impact factor: 7.196

2.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

Review 3.  Comparative study of human and rat mammary tumorigenesis.

Authors:  J Russo; B A Gusterson; A E Rogers; I H Russo; S R Wellings; M J van Zwieten
Journal:  Lab Invest       Date:  1990-03       Impact factor: 5.662

4.  Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

Authors:  Christopher I Li; Elisabeth F Beaber; Mei Tzu Chen Tang; Peggy L Porter; Janet R Daling; Kathleen E Malone
Journal:  Cancer Res       Date:  2012-02-27       Impact factor: 12.701

Review 5.  Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?

Authors:  F Clavel-Chapelon; M Gerber
Journal:  Breast Cancer Res Treat       Date:  2002-03       Impact factor: 4.872

6.  Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

Authors:  N Loman; O Johannsson; U Kristoffersson; H Olsson; A Borg
Journal:  J Natl Cancer Inst       Date:  2001-08-15       Impact factor: 13.506

7.  Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.

Authors: 
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

8.  Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women.

Authors:  F Clavel-Chapelon
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

9.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.

Authors: 
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more
  57 in total

1.  Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium.

Authors:  Lindsay A Williams; Andrew F Olshan; Chi-Chen Hong; Elisa V Bandera; Lynn Rosenberg; Ting-Yuan David Cheng; Kathryn L Lunetta; Susan E McCann; Charles Poole; Laurence N Kolonel; Julie R Palmer; Christine B Ambrosone; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-18       Impact factor: 4.254

Review 2.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

3.  Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.

Authors:  Masaaki Kawai; Kathleen E Malone; Mei-Tzu C Tang; Christopher I Li
Journal:  Cancer       Date:  2014-02-05       Impact factor: 6.860

Review 4.  Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Authors:  Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-22       Impact factor: 2.673

Review 5.  Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.

Authors:  Alex J Gooding; William P Schiemann
Journal:  Mol Cancer Res       Date:  2020-06-05       Impact factor: 5.852

6.  Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Authors:  Marilyn L Kwan; Philip S Bernard; Candyce H Kroenke; Rachel E Factor; Laurel A Habel; Erin K Weltzien; Adrienne Castillo; Erica P Gunderson; Kaylynn S Maxfield; Inge J Stijleman; Bryan M Langholz; Charles P Quesenberry; Lawrence H Kushi; Carol Sweeney; Bette J Caan
Journal:  J Natl Cancer Inst       Date:  2015-04-28       Impact factor: 13.506

Review 7.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

8.  Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent.

Authors:  Maria Elena Martinez; Betsy C Wertheim; Loki Natarajan; Richard Schwab; Melissa Bondy; Adrian Daneri-Navarro; Maria Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Abenaa Brewster; Ian K Komenaka; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

9.  Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lucile L Adams-Campbell; Lynn Rosenberg; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-18       Impact factor: 4.254

10.  Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.

Authors:  Lynn Chollet-Hinton; Andrew F Olshan; Hazel B Nichols; Carey K Anders; Jennifer L Lund; Emma H Allott; Traci N Bethea; Chi-Chen Hong; Stephanie M Cohen; Thaer Khoury; Gary R Zirpoli; Virginia F Borges; Lynn A Rosenberg; Elisa V Bandera; Christine B Ambrosone; Julie R Palmer; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-09-13       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.